Professor of Surgery
Cleveland Clinic College of Medicine at
Case Western Reserve University
Case Western Reserve University
Chairman
Cleveland Clinic
Cleveland, Ohio
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
Is Transfemoral CAS Being Overused One Year After CMS Increased Reimbursement For Treating Asymptomatic Carotid Stenosis
9:02 AM - 9:07 AM
Session Moderator
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Presenter
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT-GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
3-Year Results With Percutaneous (PQ) Transvenous FemPop PTFE Bypasses Using The Torus 2 Endograft (From Endologix): How Is It Done And Updated Results From The US DETOUR Trial: Does It Have Limitations
2:43 PM - 2:48 PM
Presenter
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Time To Perfusion In ALI: Which Is Faster, Lightning Bolt 7 (Penumbra) Or Open Surgical Embolectomy: When Is Open Surgery Necessary In 2024
5:52 PM - 5:57 PM
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent FemPop Lesions At 5 Years In The ILLUMENATE US And European RCTs
11:06 AM - 11:11 AM
Presenter
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Transcaval Approach For Endoleak Embolization: A Minimally Invasive Hot Needle Approach And Other Technical Tips Including How To Close The Aortic Access Site
10:23 AM - 10:28 AM
Presenter
SESSION 36: MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTS, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
Vascular Surgery Needs An Independent ABMS Approved Board And Associated RRC To Thrive As A Specialty In The Medical Hierarchy And To Have Its Value Appropriately Recognized
2:30 PM - 2:35 PM
Presenter
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
Status Of The Low Profile Alto Endograft (From Endologix) With More Proximal Polymer Sealing Rings For Standard EVAR: Up To 5-Year Results Show Its Advantages: Status Of The JAGUAR RCT Comparing It With Standard EVAR Endografts
8:24 AM - 8:29 AM
Presenter
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
Neuroguard 3-In-1 Carotid Stent System (Contego Medical) With Integrated Balloon, Stent And Distal Filter: Trial Results And Advantages Including Preventing Particulate Emboli Released During Presumed Flow Reversal Protected CAS From Reaching The Brain (Or Distal Filter)
10:54 AM - 10:59 AM
Moderator
SESSION 13: Frank J. Veith International Society Associate Faculty Program Presentations – Part I
OPEN VASCULAR TECHNIQUES
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
MODERATOR
3:00 PM - 5:00 PM
PRESENTER
4:37 PM - 4:44 PM
Functional Popliteal Entrapment Release
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
MODERATOR
3:00 PM - 5:00 PM
PRESENTER
4:37 PM - 4:44 PM
Functional Popliteal Entrapment Release